Document Detail


Evaluation of Drug-Induced Serious Hepatotoxicity (eDISH): Application of this Data Organization Approach to Phase III Clinical Trials of Rivaroxaban after Total Hip or Knee Replacement Surgery.
MedLine Citation:
PMID:  21332248     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Background: The most specific indicator of a drug-induced liver injury signal in a clinical trial database is believed to be the occurrence of subjects experiencing drug-associated elevations in both serum ALT and serum total bilirubin (TB) without a significant elevation in serum alkaline phosphatase (ALP). eDISH (evaluation of Drug-Induced Serious Hepatotoxicity) is a recently described tool that organizes liver laboratory data by graphically displaying peak serum ALT and TB levels for each subject, and can also provide direct links to the pertinent clinical and laboratory data for each subject. Objective: To illustrate the usefulness of the eDISH approach in the presentation of liver safety data by using phase III clinical trial data for rivaroxaban. Methods: Four randomized, active-controlled studies were conducted worldwide in subjects undergoing elective hip or knee replacement surgery to compare the efficacy and safety of the anticoagulant rivaroxaban, an oral, direct Factor Xa inhibitor, with the low-molecular-weight heparin, enoxaparin. Liver laboratory assessments, including ALT, AST, TB and ALP, were performed frequently during the studies. Data were incorporated into eDISH and linked data for selected subjects were analysed. Results: In the pooled analysis of the four studies, a total of 12 262 subjects (6131 rivaroxaban, 6131 enoxaparin) received at least one dose of study drug and had at least one central and/or local laboratory assessment during the study. A total of 143 (2.33%) rivaroxaban subjects and 223 (3.64%) enoxaparin subjects experienced a peak ALT >3 × upper limit of normal (ULN) but did not experience an elevation of TB >2 × ULN; these subjects are displayed in the right lower quadrant of the eDISH plot, termed the 'Temple's Corollary quadrant'. There were ten rivaroxaban and ten enoxaparin subjects with a peak ALT >3 × ULN and a peak TB >2 × ULN; these subjects were displayed in the right upper quadrant of the eDISH plot, termed the 'Hy's Law quadrant'. eDISH allowed efficient examination of the relevant data for each of these subjects. Conclusions: The eDISH approach is an efficient and effective way to organize and examine large liver safety databases for randomized controlled clinical trials. It greatly facilitates a systematic and transparent examination of the relevant liver safety laboratory data. We believe eDISH should become a standard approach for assessing and studying liver safety issues in clinical trials.
Authors:
Paul B Watkins; Mehul Desai; Scott D Berkowitz; Gary Peters; Yves Horsmans; Dominique Larrey; Willis Maddrey
Related Documents :
23796828 - Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-peg-gelatin polymer nanocompos...
24410438 - Translocator protein ligand-plga conjugated nanoparticles for 5-fluorouracil delivery t...
766638 - Intravitreal effects of pimaricin in experimental fungal endophthalmitis.
23707228 - Determination of p-glycoprotein surface expression and functional ability after in vitr...
22345878 - Role of acamprosate in sensorineural tinnitus.
18363148 - An in vitro evaluation of fenugreek mucilage as a potential excipient for oral controll...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Drug safety : an international journal of medical toxicology and drug experience     Volume:  34     ISSN:  0114-5916     ISO Abbreviation:  Drug Saf     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-02-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9002928     Medline TA:  Drug Saf     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  243-52     Citation Subset:  IM    
Affiliation:
Hamner-UNC Institute for Drug Safety Sciences, Research Triangle Park, North Carolina, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A computerized adverse drug event alerting system using clinical rules: a retrospective and prospect...
Next Document:  Reporting Patterns Indicative of Adverse Drug Interactions: A Systematic Evaluation in VigiBase.